Xenon Pharmaceuticals Inc (FRA:XP0)
€ 42.4 0.6 (1.44%) Market Cap: 3.16 Bil Enterprise Value: 2.50 Bil PE Ratio: 0 PB Ratio: 4.10 GF Score: 41/100

Q3 2021 Xenon Pharmaceuticals Inc Earnings Call Transcript

Nov 10, 2021 / 09:30PM GMT
Release Date Price: €30.4 (+4.83%)
Operator

Good day, and thank you for standing by. Welcome to the Third Quarter 2021 Xenon Pharmaceuticals Incorporated Earnings Conference Call. (Operator Instructions) I would now like to hand the conference over to your first speaker for today, Ms. Sherry Aulin, the Chief Financial Officer of Xenon Pharmaceuticals. Please go ahead.

Sherry Aulin
Xenon Pharmaceuticals Inc. - CFO

Thank you. Good afternoon, everyone. Thank you for joining us on our call and webcast to discuss our third quarter 2021 financial and operating results. Joining me are Ian Mortimer, Xenon's President and Chief Executive Officer; Dr. Chris Kenney, Xenon's Chief Medical Officer; and Dr. Chris Von Seggern, Xenon's Chief Commercial Officer. Today, Ian will provide a corporate update on our proprietary programs and then turn the call over to Chris Kenney, who will provide a summary of the X-TOLE data and our XEN1101 plans moving forward. Chris Von Seggern will then provide context regarding the adult focal epilepsy market based on market research with leading KOLs and treating physicians. Lastly, I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot